STEADY-STATE LITHIUM BLOOD LEVEL FLUCTUATIONS IN MAN FOLLOWING ADMINISTRATION OF A LITHIUM-CARBONATE CONVENTIONAL AND CONTROLLED-RELEASE DOSAGE FORM

被引:18
作者
CALDWELL, HC
WESTLAKE, WJ
SCHRIVER, RC
BUMBIER, EE
机构
关键词
D O I
10.1002/j.1552-4604.1981.tb01758.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:106 / 109
页数:4
相关论文
共 9 条
[1]  
AMDISEN A, 1968, ACTA PHARM SUEC, V5, P465
[2]  
CALDWELL HC, 1971, J CLIN PHARMACOL N D, V11, P349
[3]  
COOPER TB, 1978, AM J PSYCHIAT, V135, P917
[4]  
COPPEN A, 1969, J CLIN PHARMACOL N D, V9, P160
[5]   PRIORI LITHIUM DOSAGE REGIMEN USING POPULATION CHARACTERISTICS OF PHARMACOKINETIC PARAMETERS [J].
GAILLOT, J ;
STEIMER, JLJ ;
MALLET, AJ ;
THEBAULT, JJ ;
BIEDER, A .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (06) :579-628
[6]   SUSTAINED-RELEASE LITHIUM-CARBONATE IN A DOUBLE-BLIND-STUDY - SERUM LITHIUM LEVELS, SIDE-EFFECTS, AND PLACEBO RESPONSE [J].
MARINI, JL ;
SHEARD, MH .
JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (5-6) :276-283
[7]  
OTTO U, 1972, ACTA PHARM SUEC, V9, P595
[8]   DOSAGE FORM INDEX - OBJECTIVE CRITERION FOR EVALUATION OF CONTROLLED-RELEASE DRUG DELIVERY SYSTEMS [J].
THEEUWES, F ;
BAYNE, W .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (10) :1388-1392